Schizophrenia Support Forum
EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan -
News on schizophrenia and mental health matters
everhopeful
January 8, 2026, 5:47pm
1
9 Likes
Related topics
Topic
Replies
Views
Activity
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
News on schizophrenia and mental health matters
0
71
May 3, 2026
Newron Fortifies Evenamide Phase III Push with Fresh Capital, Patent Win and Board Overhaul
News on schizophrenia and mental health matters
4
85
March 27, 2026
Newron Pharmaceuticals Secures Up To €38 Million To Advance Phase III Evenamide Program
News on schizophrenia and mental health matters
3
105
February 25, 2026
US FDA flags four deaths in Newron's schizophrenia drug studies (Evenamide)
News on schizophrenia and mental health matters
18
217
October 11, 2026
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics
Medications
2
102
February 9, 2026